机译:Anstrozole用于预防乳腺癌(Ibis-II):随机对照试验的长期结果
Queen Mary Univ London Wolfson Inst Prevent Med Ctr Canc Prevent London EC1M 6BQ England;
Queen Mary Univ London Wolfson Inst Prevent Med Ctr Canc Prevent London EC1M 6BQ England;
Univ Newcastle Australia New Zealand Breast Canc Trials Grp Newc Calvary Mater Hosp Waratah NSW;
Royal Marsden Ralph Lauren Ctr Breast Canc Res London England;
Southmead Hosp Breast Care Ctr Bristol Avon England;
Univ Wales Coll Cardiff Coll Med Univ Dept Surg Cardiff Wales;
German Breast Grp Frankfurt Germany;
European Inst Oncol Div Chemoprevent &
Genet Milan Italy;
Manchester Univ NHS Fdn Trust Nightingale Breast Screening Ctr Prevent Breast Canc Unit;
Manchester Univ NHS Fdn Trust Nightingale Breast Screening Ctr Prevent Breast Canc Unit;
机译:Anstrozole用于预防乳腺癌(Ibis-II):随机对照试验的长期结果
机译:阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防(IBIS-II DCIS):一项双盲,随机对照试验
机译:阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防(IBIS-II DCIS):一项双盲,随机对照试验
机译:预防芳族酶抑制剂 - 来自ATAC(ARIMIDEX,Tamoxifen单独或组合或组合的数据)的数据和IBIS-II的设计(第二次国际乳腺癌干预研究)
机译:性与妇科癌症:一项随机对照试验,旨在评估团体心理教育干预措施对经放射治疗的妇科癌症妇女改善性健康的有效性
机译:阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防(IBIS-II DCIS):一项双盲随机对照试验
机译:Anstrozole用于预防乳腺癌(Ibis-II):随机对照试验的长期结果